Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Peptide Based Infection Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Peptide Based Infection Therapeuticsmarket, defines the market attractiveness level of Peptide Based Infection Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Peptide Based Infection Therapeutics industry, describes the types of Peptide Based Infection Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Peptide Based Infection Therapeutics market and the development prospects and opportunities of Peptide Based Infection Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Peptide Based Infection Therapeutics market in Chapter 13.
By Player:
Gilead Sciences
Johnson & Johnson (Janssen)
Medivir
Vertex Pharmaceuticals
Mitsubishi Tanabe Pharma
By Type:
Telaprevir
Sofosbuvir
Others
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Peptide Based Infection Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Peptide Based Infection Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Peptide Based Infection Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Peptide Based Infection Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Peptide Based Infection Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Peptide Based Infection Therapeutics Consumption (2017-2022)
-
7.2 United States Peptide Based Infection Therapeutics Consumption (2017-2022)
-
7.3 Europe Peptide Based Infection Therapeutics Consumption (2017-2022)
-
7.4 China Peptide Based Infection Therapeutics Consumption (2017-2022)
-
7.5 Japan Peptide Based Infection Therapeutics Consumption (2017-2022)
-
7.6 India Peptide Based Infection Therapeutics Consumption (2017-2022)
-
7.7 South Korea Peptide Based Infection Therapeutics Consumption (2017-2022)
8 Region and Country-wise Peptide Based Infection Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Peptide Based Infection Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Peptide Based Infection Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Peptide Based Infection Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Peptide Based Infection Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Peptide Based Infection Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Peptide Based Infection Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Peptide Based Infection Therapeutics Consumption Forecast (2022-2028)
9 Global Peptide Based Infection Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Peptide Based Infection Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Telaprevir Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Sofosbuvir Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Peptide Based Infection Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Peptide Based Infection Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Peptide Based Infection Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Telaprevir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Sofosbuvir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Peptide Based Infection Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Peptide Based Infection Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Peptide Based Infection Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Peptide Based Infection Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Peptide Based Infection Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Peptide Based Infection Therapeutics Market Competitive Analysis
-
14.1 Gilead Sciences
-
14.1.1 Gilead Sciences Company Details
-
14.1.2 Gilead Sciences Peptide Based Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Gilead Sciences Peptide Based Infection Therapeutics Product and Service
-
14.2 Johnson & Johnson (Janssen)
-
14.2.1 Johnson & Johnson (Janssen) Company Details
-
14.2.2 Johnson & Johnson (Janssen) Peptide Based Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Johnson & Johnson (Janssen) Peptide Based Infection Therapeutics Product and Service
-
14.3 Medivir
-
14.3.1 Medivir Company Details
-
14.3.2 Medivir Peptide Based Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Medivir Peptide Based Infection Therapeutics Product and Service
-
14.4 Vertex Pharmaceuticals
-
14.4.1 Vertex Pharmaceuticals Company Details
-
14.4.2 Vertex Pharmaceuticals Peptide Based Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Vertex Pharmaceuticals Peptide Based Infection Therapeutics Product and Service
-
14.5 Mitsubishi Tanabe Pharma
-
14.5.1 Mitsubishi Tanabe Pharma Company Details
-
14.5.2 Mitsubishi Tanabe Pharma Peptide Based Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Mitsubishi Tanabe Pharma Peptide Based Infection Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Peptide Based Infection Therapeutics
-
Figure Peptide Based Infection Therapeutics Picture
-
Table Global Peptide Based Infection Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peptide Based Infection Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peptide Based Infection Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Peptide Based Infection Therapeutics Consumption by Country (2017-2022)
-
Figure United States Peptide Based Infection Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Peptide Based Infection Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Peptide Based Infection Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Peptide Based Infection Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Peptide Based Infection Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Peptide Based Infection Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Peptide Based Infection Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Peptide Based Infection Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Peptide Based Infection Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Peptide Based Infection Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Peptide Based Infection Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Peptide Based Infection Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Peptide Based Infection Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Telaprevir Consumption and Growth Rate (2017-2022)
-
Figure Global Sofosbuvir Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Telaprevir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sofosbuvir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Peptide Based Infection Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Peptide Based Infection Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Peptide Based Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Peptide Based Infection Therapeutics Product and Service
-
Table Johnson & Johnson (Janssen) (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson (Janssen) Peptide Based Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson (Janssen) Peptide Based Infection Therapeutics Product and Service
-
Table Medivir (Foundation Year, Company Profile and etc.)
-
Table Medivir Peptide Based Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medivir Peptide Based Infection Therapeutics Product and Service
-
Table Vertex Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Vertex Pharmaceuticals Peptide Based Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vertex Pharmaceuticals Peptide Based Infection Therapeutics Product and Service
-
Table Mitsubishi Tanabe Pharma (Foundation Year, Company Profile and etc.)
-
Table Mitsubishi Tanabe Pharma Peptide Based Infection Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mitsubishi Tanabe Pharma Peptide Based Infection Therapeutics Product and Service
-
